EVESA Trademark

Trademark Overview

On Saturday, June 19, 2010, a trademark application was filed for EVESA with the United States Patent and Trademark Office. The USPTO has given the EVESA trademark a serial number of 79087258. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Friday, June 19, 2020. This trademark is owned by Affymax Pharma Limited. The EVESA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke
evesa

General Information

Serial Number79087258
Word MarkEVESA
Filing DateSaturday, June 19, 2010
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateFriday, June 19, 2020
Registration Number4097602
Registration DateTuesday, February 14, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 28, 2011

Trademark Statements

Certificate of Correction for RegistrationLine 6, "cancer" should be deleted.
Goods and ServicesPharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 21, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAffymax Pharma Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB
Party NameAffymax Pharma Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB
Party NameAffymax Pharma Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events

Event DateEvent Description
Saturday, July 10, 2021NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Saturday, July 10, 2021DEATH OF INTERNATIONAL REGISTRATION
Friday, November 29, 2019TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, June 13, 2019TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, June 13, 2019INVALIDATION PROCESSED
Tuesday, May 21, 2019TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, September 21, 2018CANCELLED SECTION 71
Tuesday, February 14, 2017COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, August 4, 2016NEW REPRESENTATIVE AT IB RECEIVED
Monday, March 10, 2014INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Friday, October 11, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 4, 2013PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Wednesday, August 29, 2012FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, August 6, 2012FINAL DISPOSITION NOTICE SENT TO IB
Monday, August 6, 2012FINAL DISPOSITION PROCESSED
Saturday, August 4, 2012CORRECTION UNDER SECTION 7 ¿ PROCESSED
Friday, August 3, 2012ASSIGNED TO PARALEGAL
Monday, May 14, 2012FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, February 14, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, January 10, 2012EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Monday, November 28, 2011TEAS VOLUNTARY AMENDMENT RECEIVED
Sunday, September 4, 2011NOTIFICATION PROCESSED BY IB
Thursday, July 21, 2011EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, June 28, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 28, 2011PUBLISHED FOR OPPOSITION
Wednesday, June 15, 2011NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, June 15, 2011NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Friday, May 20, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 18, 2011ASSIGNED TO LIE
Thursday, May 5, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 26, 2011ASSIGNED TO EXAMINER
Wednesday, April 20, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 20, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 20, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 2, 2010ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 2, 2010TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 10, 2010REFUSAL PROCESSED BY IB
Thursday, October 21, 2010NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, October 21, 2010REFUSAL PROCESSED BY MPU
Thursday, October 21, 2010NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, October 20, 2010NON-FINAL ACTION WRITTEN
Tuesday, October 19, 2010APPLICATION FILING RECEIPT MAILED
Friday, October 15, 2010ASSIGNED TO EXAMINER
Friday, October 15, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, October 14, 2010SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

evesa failure pharmaceuticals cellular induced degeneration heart stroke hypoxia renal congestive